Lucké 1 has determined the survival time in 100 fatal cases of lower-nephron nephrosis. Ninety-five per cent of the patients succumbed within fourteen days, 86 per cent within ten days ...

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) shareholders might be concerned after seeing the share price drop 24% in the last quarter. But don't let that distract from the very nice return generated ...

The paper aimed to assess when any existing ion drive technology could port a large payload on one of several trajectories, including a trip around Jupiter, one visiting Pluto, and even one ...

The IONS 2024 Joint Naval Exercise, also known as the Indian Ocean Naval Symposium (IONS) Maritime Exercise (IMEX) 2024, was organized by Iran in its southern maritime territory. The exercise, which ...

I have been considering Ionis (NASDAQ:IONS) as a potential "strong buy" opportunity for some time. I covered the Carlsbad, California-based developer of antisense, oligonucleotide therapeutics on ...

Lithium-ion (Li-ion) battery technology has historically been the power cell of choice, especially given that we’re always all looking to maximize our smartphone’s battery life. However ...

A white precipitate forms if sulfate ions are present. Explain why, in a test for sulfate ions, the sample is acidified with hydrochloric acid first. Carbonate ions also produce a white ...

Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. It operates through the Ionis Core and Akcea Therapeutics segments.

When dissolved in water, potassium produces positively charged ions. This special property allows it to conduct electricity, which is important for many processes throughout your body. This ...